Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nateglinide vs Glimepiride Durability in Type 2 Diabetes
NCT00858013Phase 4Completed
- Sponsor
- Ajou University School of Medicine
- Start
- Apr 2009
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nateglinide in type 2 diabetes mellitus (T2DM), sponsored by Ajou University School of Medicine. Started Apr 2009; status: completed.
02
Drugs
nateglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00858013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00858013.